PHENOXYBENZAMINE HCL

Phenoxybenzamine HCl is an irreversible alphaadrenergic antagonist that reduces vascular resistance and blood pressure. It is used for pheochromocytoma management and certain autonomic dysfunctions. Side effects include orthostatic hypotension, tachycardia, nasal congestion, fatigue, and ejaculation disorders. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 344be3afccec Category: Tag:

Product Description


Mechanism of Action

PHENOXYBENZAMINE HCL demonstrates a broad, multilayer biochemical activity profile affecting enzymedriven catalytic pathways, receptorregulated signalling systems, mitochondrial bioenergetics, redoxstate equilibrium, ionchannel behaviour, cytoskeletal integrity and transcriptionfactor regulatory networks. Its structural features indicate potential interactions with catalytic residues, allosteric protein domains, membranebound receptors and intracellular signalling intermediates, enabling influence over phosphorylation kinetics, Ca²⁺/cAMP/IP/DAGmediated secondmessenger systems, ATP turnover, ROS buffering and mitochondrial respiratorychain performance.

Depending on concentration and biological conditions, PHENOXYBENZAMINE HCL may modulate metabolic flux distribution, alter mitochondrial membrane potential, influence chromatin accessibility, impact vesicular trafficking dynamics and reshape geneexpression patterns relevant to survival, inflammation, apoptosis, autophagy, metabolic adaptation and redoxstress response.

Benefits and Advantages

This compound is widely used across advanced biochemical, pharmacological and mechanistic research domains, including:

  • Receptorligand interaction studies and affinitymapping
  • Enzymekinetic pathway deconstruction and catalyticdomain profiling
  • Mitochondrialfunction analysis and ATPflux/oxidativestress modelling
  • Multiomics integration (transcriptomics, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletalstructure and membranedynamics research
  • Autophagy, apoptosis, necroptosis and ferroptosis signalling investigations
  • SAR (structureactivity relationship) profiling and compoundoptimisation workflows
  • Pharmacodynamic modelling, thresholdactivation mapping and doseresponse scaling

Side Effects and Risks

Laboratoryobserved or predicted risks include:

  • Oxidative imbalance and excessive ROS accumulation
  • Mitochondrial overload or respiratorychain suppression
  • Dysregulation of Na⁺/K⁺/Ca²⁺ ionchannel homeostasis
  • Unintended receptor crosstalk or inhibitory interference
  • Cytoskeletal destabilisation and membrane-integrity disruption
  • Dosedependent cytotoxicity with apoptosis/autophagy activation
  • Transcriptional instability or epigenetic disturbance
  • Inflammatory signalling activation via NF-κB, MAPK or JNK pathways

Use strictly within controlled laboratory environments under appropriate biosafety protocols.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C18H22ClNO·HCl

Molecular Weight

340.3 g/mol

CAS Number

63-92-3

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

less than 0.1 mg/mL at 65.3 °F (NTP, 1992)

Purity

Purity information is available upon request (COA).

Synonym

Phenoxybenzamine hydrochloride; 63-92-3; Phenoxybenzamine Hcl; Dibenzyline hydrochloride; Dibenzyline chloride

IUPAC/Chemical Name

N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine;hydrochloride

InChl Key

VBCPVIWPDJVHAN-UHFFFAOYSA-N

InChl Code

InChI=1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H

References

https://pubchem.ncbi.nlm.nih.gov/compound/5284441;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download